How to Buy Argenx Se Stock
Argenx Se
"a"r"g"e"n"x" "S"E"," "a" "b"i"o"t"e"c"h"n"o"l"o"g"y" "c"o"m"p"a"n"y"," "f"o"c"u"s"e"s" "o"n" "d"e"v"e"l"o"p"i"n"g" "v"a"r"i"o"u"s" "t"h"e"r"a"p"i"e"s" "f"o"r" "t"h"e" "t"r"e"a"t"m"e"n"t" "o"f" "a"u"t"o"i"m"m"u"n"e" "d"i"s"e"a"s"e"s" "i"n" "t"h"e" "U"n"i"t"e"d" "S"t"a"t"e"s"," "t"h"e" "N"e"t"h"e"r"l"a"n"d"s"," "B"e"l"g"i"u"m"," "J"a"p"a"n"," "S"w"i"t"z"e"r"l"a"n"d"," "G"e"r"m"a"n"y" "a"n"d" "F"r"a"n"c"e".
Argenx Se stock last closed at $603.40, down 0.41% from the previous day, and has increased 33.31% in one year. It has overperformed other stocks in the Biotechnology industry by 0.53 percentage points. Argenx Se stock is currently +84.12% from its 52-week low of $327.73, and -4.22% from its 52-week high of $630.00.
As of Dec 12, 2024, there are 59.8M ARGX shares outstanding. The market capitalization of ARGX is $36.08B. In the last 24 hours, 200,124 ARGX shares were traded.
How to Buy Argenx Se Stock
Wondering how to invest in Argenx Se stock? Here's how.
- Figure out where to buy Argenx Se stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Argenx Se stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your payment method and add your details.
- Research Argenx Se stock: The Argenx Se ticker symbol is ARGX. Is Argenx Se stock a good investment? Should you buy shares of ARGX? How do ARGX's underlying business fundamentals look? Do top analysts think Argenx Se is a good buy? Why has ARGX's stock price moved recently? (Hint: Our stock research website can help you understand if ARGX is a good stock to buy).
- Execute your ARGX trade: Decide if you will purchase ARGX shares at the current market price or use a limit order to buy ARGX stock at a particular price.
- Monitor your investment in ARGX: Create a watchlist to keep tabs on your new investment in Argenx Se stock.
Step 1: Figure out where to buy Argenx Se stock
You need an online brokerage account in order to access the NASDAQ market and buy ARGX stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you are able to buy ARGX stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on the best stock trading app, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your investment account.
Step 4: Research Argenx Se stock
After you have figured out the best place to buy Argenx Se stock, it's absolutely critical to research their stock before you buy, so you truly wrap your head around the risk as well as the opportunity.
Argenx Se quick stats
Argenx Se Due Diligence Checks
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on ARGX's stock page.
Is ARGX stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ARGX's true value.
Using relative valuations ratios:
- ARGX could be overvalued based on its P/B ratio of 7.79x, relative to Biotechnology industry P/B ratio of 5.46x
You can do more valuation analysis on ARGX's stock here.
A quick look at ARGX Financials
Pros:
- ARGX has $3.37B in cash and short term investments. This is sufficient to cover its annual cash burn of $308.95M.
- There are more short-term assets than short-term liabilities on the ARGX balance sheet.
- Total ARGX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the ARGX balance sheet.
- ARGX has cash burn of 308948913. It has sufficient cash and short-term investments to cover this for at least one year.
- ARGX has a low debt to equity ratio of 0.13.
Cons:
- ARGX profit margin has gone up by 34.93 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy ARGX stock, according to Wall Street analysts?
Out of 17 sell side analysts who give forecasts on ARGX, the consensus analyst rating on ARGX is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest ARGX Analyst Ratings
James Gordon, a top 39% analyst from JP Morgan maintains ARGX with a strong buy rating and raises their ARGX price target from $640.00 to $670.00, on Nov 4, 2024.
Yatin Suneja, a bottom 13% analyst from Guggenheim maintains ARGX with a strong buy rating and raises their ARGX price target from $585.00 to $665.00, on Nov 1, 2024.
Derek Archila, a top 3% analyst from Wells Fargo maintains ARGX with a strong buy rating and raises their ARGX price target from $547.00 to $639.00, on Nov 1, 2024.
Allison Bratzel, a top 17% analyst from Piper Sandler maintains ARGX with a strong buy rating and raises their ARGX price target from $553.00 to $620.00, on Nov 1, 2024.
Piper Sandler's Allison Bratzel raised their price target on Argenx Se (NASDAQ: ARGX) by 12.1% from $553 to $620 on 2024/11/01. The analyst maintained their Strong Buy rating on the stock.
Argenx SE reported its Q3 2024 earnings.
Vyvgart had "another strong showing" in the quarter, Bratzel told investors.
The analyst predicted that Argenx SE's "growing dominance" in the neuromuscular arena would be sustained, citing the quarter's metrics.
As a result, Piper Sandler maintained its Strong Buy rating on the stock, Bratzel added.
Overall, the analyst said, with Vyvgart's clinical profile, Argenx SE has established itself as a "dominant player" in the field of generalized myasthenia gravis and set an "extremely high bar" for other players.
Earnings Report
For Q3 2024, Argenx Se reported:
- EPS of $1.39, compared to Q3 2023’s loss of $1.25.
- Revenue of $573M, up 74.1% Y/Y.
Management did not provide EPS and revenue guidance.
CEO Tim Van Hauwermeiren commented: “We delivered significant patient impact with VYVGART over the quarter, expanding our gMG footprint and delivering innovation to CIDP patients three months into launch.
“We continued to advance our goal of reaching more gMG patients earlier in their treatment journey, supported by VYVGART’s strong safety and efficacy profile, and real-world data showing the ability to reduce steroid use meaningfully.
“Expanding upon our leadership in gMG, we are now paving the future in CIDP.
“The strength of our data, combined with execution across the team to reach key stakeholders, contributed to the initial success of our CIDP launch, with more than 300 patients on therapy at the end of Q3.
“There remains significant opportunity ahead as we work towards achieving our Vision 2030, with innovation implemented across our pipeline to deliver transformative outcomes to more patients.”
Jason Butler, a top 23% analyst from JMP Securities maintains ARGX with a buy rating and raises their ARGX price target from $497.00 to $606.00, on Nov 1, 2024.
You can dig deeper into what analysts are forecasting on the Argenx Se stock forecast page.
ARGX Technicals
Is ARGX Making Money?
Last year, ARGX revenue was $39.02M. During the past 5 year, ARGX's revenue has gone up by -6.33% per year. This was slower than the Biotechnology industry average of 63.4%.
You can analyze ARGX's earnings and revenue performance here.
Who is buying/selling ARGX?
Over the past year, insiders at ARGX have not bought or sold any shares.
Learn more about who owns ARGX stock here.
Can I get consistent income from ARGX stock?
No, Argenx Se doesn't provide an income stream by paying out dividends.
What others are saying about ARGX
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your ARGX trade
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.
Click the Open button and your broker will execute your order.
If you require additional info about buying stocks on eToro, click the how to video below:
Step 6: Monitor your investment in ARGX
Now that you own some ARGX stock, you'll want to stay up-to-date on your company.
Start a watchlist to track your ARGX stock.
ARGX Feed
How to Buy Stock in Argenx Se
To reiterate, here are the 6 steps for buying Argenx Se stock:
- Figure out where to buy Argenx Se stock
- Create your brokerage account
- Deposit funds into your investment account
- Research Argenx Se stock
- Execute your ARGX trade
- Monitor your investment in ARGX
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Argenx Se, click below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.